Abiraterone acetate, enzalutamide and their sequence for castration-resistant prostate cancer

Badereddin Mohamad Al-Ali,Klaus Eredics,Stephan Madersbacher,Ingrid Schauer

Abiraterone acetate, enzalutamide and their sequence for castration-resistant prostate cancer

2018

Badereddin Mohamad Al-Ali
Klaus Eredics
Stephan Madersbacher
Ingrid Schauer

Objective To analyze drug adherence, overall survival (OS) and hospitalization rates of patients with castration-resistant prostate cancer (CRPC) treated with arbiraterone acetate (AA), enzalutamide (ENZ) and their sequence in a real-life setting.

Keywords:

Abiraterone acetate
Pathology
Prostate cancer
Cancer research
Castration
Medicine
Enzalutamide
Cohort
castration resistant
Medical prescription
prescription database
Internal medicine
remaining life

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations